Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 15,031 | 13,801 | 16,024 | 16,885 | 13,066 |
| Cost of Goods | 6,012 | 5,530 | 6,005 | 4,281 | 2,653 |
| Gross Profit | 9,019 | 8,271 | 10,019 | 12,604 | 10,413 |
| Operating Expenses | 20,202 | 26,097 | 35,055 | 33,267 | 23,106 |
| Operating Income | -11,171 | -17,296 | -25,031 | -20,382 | -12,040 |
| Interest Expense | 0 | 0 | 0 | 14 | 96 |
| Other Income | 35 | 3,713 | 1,186 | 108 | 79 |
| Pre-tax Income | -11,136 | -13,583 | -23,845 | -20,288 | -12,057 |
| Net Income Continuous | -11,136 | -13,583 | -23,845 | -20,288 | -12,057 |
| Net Income | $-11,136 | $-13,583 | $-23,845 | $-20,288 | $-12,057 |
| EPS Basic Total Ops | -2.22 | -11.14 | -25.90 | -24.00 | -35.00 |
| EPS Basic Continuous Ops | -2.22 | -11.14 | -25.89 | -23.89 | -23.42 |
| EPS Diluted Total Ops | -2.22 | -11.14 | -25.90 | -24.00 | -35.00 |
| EPS Diluted Continuous Ops | -2.22 | -11.14 | -25.89 | -23.89 | -23.42 |
| EPS Diluted Before Non-Recurring Items | -2.22 | -13.03 | -26.00 | -24.00 | -35.00 |
| EBITDA(a) | $-10,590 | $-16,675 | $-24,362 | $-19,649 | $-11,322 |